Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Mar 07, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000024.pdf 0001765581-23-000024.rtf 0001765581-23-000024.xls
Mar 07, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000028.pdf 0001765581-23-000028.rtf 0001765581-23-000028.xls
Mar 07, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000026.pdf 0001765581-23-000026.rtf 0001765581-23-000026.xls
Mar 07, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000032.pdf 0001765581-23-000032.rtf 0001765581-23-000032.xls
Mar 07, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000030.pdf 0001765581-23-000030.rtf 0001765581-23-000030.xls
Mar 09, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000034.pdf 0001765581-23-000034.rtf 0001765581-23-000034.xls
Mar 10, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000036.pdf 0001765581-23-000036.rtf 0001765581-23-000036.xls
Mar 17, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000038.pdf 0001765581-23-000038.rtf 0001765581-23-000038.xls
Apr 07, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001765581-23-000040.pdf 0001765581-23-000040.rtf 0001765581-23-000040.xls
May 01, 2023	10-K/A	Amendment to a previously filed 10-K	Annual Filings	View HTML 0001193125-23-130405.pdf 0001193125-23-130405.rtf 0001193125-23-130405.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.